Navigation Links
International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification
Date:3/9/2010

COLUMBIA, S.C., March 9 /PRNewswire/ -- Conformity markings allow Rhythmlink International products to be marketed throughout Europe, launching Rhythmlink to a new level within the neurodiagnostic and health care industry.

As of January 28, 2010, Rhythmlink International received ISO 13485:2003 certification, in combination with official CE markings, following MDD 93/42/ECC Directives. Rhythmlink's quality management system was audited in accordance with ISO 13485:2003 and is recognized by the Canadian Medical Devices Conformity Assessment Scheme [CMDCAS] and the Standards Council of Canada [SCC] accredited notified body, TUV Rheinland.

Effective immediately, Rhythmlink may sell and market product within the European Union [EU] and partnering nations. "Our ISO 13485:2003 certification is key to the growth of the company. This certification demonstrates to the markets in the European Union that Rhythmlink will provide products backed by a quality management system that reduces risk to patients," said Martin Barry, Rhythmlink International's regulatory affairs specialist.

As an electrode manufacturing company, within the medical devices industry, Rhythmlink International is bound by strict FDA regulations and regulatory requirements. Rhythmlink's quality management system has demonstrated the ability to provide medical devices and services that consistently achieve customer and regulatory requirements, thus receiving ISO 13485:2003 certification and ISO 13485:2003 + AC:2007 CE Markings.

Under European Directives and supported by European standards, Rhythmlink and its products are in full compliance with essential health and safety requirements. The CE Marking is Rhythmlink's declaration that all products meet the essential requirements of the European directives.

For more information about Rhythmlink's certifications, products and services, visit Rhythmlink.com.

About Rhythmlink International, LLC

Rhythmlink International, LLC designs, manufactures and distributes neurodiagnostic accessories and provides custom OEM and manufacturing solutions to its customers.  Based in Columbia, S.C., Rhythmlink was established in 2002 and is owned and operated by CEO Shawn Regan and COO Michael O'Leary.  Rhythmlink's advancements and improvements in the areas of technology, business development and corporate branding have been recognized by entities such as the Columbia Information Technology Council, Inc. Magazine and the International Academy of the Visual Arts.  For more information about Rhythmlink International, its products or services, visit Rhythmlink.com.

SOURCE Rhythmlink International, LLC

Back to top

RELATED LINKS
http://www.rhythmlink.com

'/>"/>

SOURCE Rhythmlink International, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Concentric Medical and the Merci Retrieval System(R) Highlighted at the 2010 International Stroke Conference
2. Max Neeman International and AMEDON Collaborate to Increase EDC Performance
3. International Merchant Advisors Reaches Agreement in Principal to Acquire First Medical Marijuana Clinic Operations
4. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
5. Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results
6. PRA International Hosts a Late Phase Services Webinar Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
7. Microfluidics International Corporation to Report Fourth Quarter and Year-end 2009 Financial Results on February 23, 2010
8. Cancer Expert Dr. Eric Rowinsky to Oversee Oncology Product Development at RRD International
9. International Merchant Advisors, Inc. Signs LOI to Invest in Pharmaceutical Chain
10. Max Neeman International Expands Specialized Surgical Team for Clinical Trials
11. Bacterin International Completes $3 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... 2017 Diabetic Shoes Market: Overview Read ... ... a disease, which is marked by high levels of blood ... The disease has become a global epidemic leading to serious ... organs of the body including eyes, kidneys, heart. However, it ...
(Date:2/21/2017)... 21, 2017 Medical Oxygen Concentrators Market: ... http://www.reportlinker.com/p04711311-summary/view-report.html Medical oxygen concentrators are used ... diseases. Patients having low level of oxygen in ... Oxygen concentrators are to be used only with ... Medical oxygen concentrators work either on rechargeable lithium ...
(Date:2/21/2017)... Feb. 21, 2017  Global health services company Cigna ... ® for breast reconstruction surgery and Dermacell ... an advanced acellular dermal matrix developed by LifeNet Health ... NVDQ ) "We are proud ... health-care payers to review the growing base of evidentiary ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... 21, 2017 , ... Hanna Boys Center http://www.hannacenter.org ... the keynote speaker at its second Professional Networking Breakfast on March 9, 2017. ... comprehensive strategies to create and expand opportunities for boys and young men of ...
(Date:2/21/2017)... ... February 21, 2017 , ... Ray Insurance Agencies, a Dallas ... around Tarrant County, is embarking on a six month charity event aimed at raising ... cancer. , Cancer is one of the deadliest diseases in America; more than 7.5 ...
(Date:2/21/2017)... ... February 21, 2017 , ... Each February ... History Month (officially African American History Month ). This month-long ... of a diverse race of people, but also the opportunity to examine the ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on ... loss. It found that the treatments have led to significant improvements in weight loss ... unassisted efforts. It also noted very few problematic results relating to the treatment. Beverly ...
(Date:2/20/2017)... OAK BROOK. Ill. (PRWEB) , ... February 20, 2017 , ... ... at high risk–according to a new study from Germany published online in the journal ... cancer screening modality that offers better sensitivity than mammography and ultrasound. Currently, guidelines reserve ...
Breaking Medicine News(10 mins):